Advertisement

Topics

PHARMA DISCOVERY An Elsevier Event Company Profile

09:06 EDT 24th June 2018 | BioPortfolio

Nil

Location

United States of America

Contact

Phone: 203-840-5642
Fax: 203-840-9642
Email: inquiry@pharmadiscoveryevent.com


News Articles [1549 Associated News Articles listed on BioPortfolio]

Elsevier adds six start-ups to its pharma innovation hub

Science and health information analytics business Elsevier has finalised the name of six companies that will join its innovation hub...Read More... The post Elsevier adds six start-ups to its pharma i...

Elsevier welcomes six biotech and pharma start-ups to The Hive

Start-ups working on a range of technologies and discoveries — from AI to immunotherapy — receive complimentary access to Elsevier's information solutions to accelerate innovation

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018 Reporter: Aviva Lev-Ari, PhD, RN   ANNOUNCEMENT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a selected CHI ...

Winners of the 2018 Elsevier Foundation Green and Sustainable Chemistry Challenge

(Elsevier) Two new chemistry solutions that use guava leaves to combat food spoilage and turn fish bones into phosphate rich fertilizer won the Elsevier Foundation Green and Sustainable Chemistry Chal...

Elsevier/Bayer study findings could cut animal testing

A new analysis of safety reporting data by analytics group Elsevier and Bayer has found that some animal tests are far more predictive of human response than others.

Six biotech and pharma start-ups chosen to join The Hive in second intake

Global information analytics business, Elsevier, has revealed that six biotech and pharma start-ups have been selected to join its innovation initiative, The Hive.

Why pharma needs to embrace AI to reimagine drug discovery

Ian Churcher, vice president of drug discovery at BenevolentAI, argues that pharma needs to embrace artificial…

Drugs and Medications [286 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [938 Associated PubMed Articles listed on BioPortfolio]

Removal notice to "A "cough induced" pelvic fracture as the first sign of a malignant neoplasm" IJSCR Volume 11 (2015) 75-77.

This article has been removed: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been removed at the request ...

Early Probe and Drug Discovery in Academia: A Minireview.

Drug discovery encompasses processes ranging from target selection and validation to the selection of a development candidate. While comprehensive drug discovery work flows are implemented predominant...

Leveraging Semantic Labels for Multi-level Abstraction in Medical Process Mining and Trace Comparison.

Many medical information systems record data about the executed process instances in the form of an event log. In this paper, we present a framework, able to convert actions in the event log into high...

Hundreds of German universities set to lose access to Elsevier journals.

Real world big data for clinical research and drug development.

The objective of this paper is to identify the extent to which real world data (RWD) is being utilized, or could be utilized, at scale in drug development. Through screening peer-reviewed literature, ...

Clinical Trials [1091 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [2069 Associated Companies listed on BioPortfolio]

PHARMA DISCOVERY An Elsevier Event

Nil

Elsevier MDL

Elsevier MDL is the pioneering leader in discovery informatics. Over 1,000 life science companies supercharge their discovery engines with MDL software solutions to generate fresh ideas and make break...

Elsevier and Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases...

Elsevier Properties and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Tr...

Elsevier Properties SA and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks i...

More Information about "PHARMA DISCOVERY An Elsevier Event" on BioPortfolio

We have published hundreds of PHARMA DISCOVERY An Elsevier Event news stories on BioPortfolio along with dozens of PHARMA DISCOVERY An Elsevier Event Clinical Trials and PubMed Articles about PHARMA DISCOVERY An Elsevier Event for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PHARMA DISCOVERY An Elsevier Event Companies in our database. You can also find out about relevant PHARMA DISCOVERY An Elsevier Event Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record